Eli Lilly
-
FDA approves new Alzheimer’s drug that slows memory declineA key differentiating factor for donanemab is the drug's finite dosing, which allows patients to stop taking the treatment once brain scans no longer show amyloid plaques.HealthJul 3
-
Decision on Eli Lilly’s Alzheimer’s drug delayed by U.S. FDAThe U.S. Food and Drug Administration has delayed its decision on Eli Lilly's LLY.N experimental treatment for early Alzheimer's disease.HealthMar 8
-
-
Advertisement
-
Eli Lilly’s new version of diabetes drug Mounjaro approved for weight loss by FDAA new version of the popular diabetes treatment Mounjaro from Eli Lilly can be sold as a weight-loss drug, U.S. regulators announced Wednesday.HealthNov 8, 2023
-
-
Advertisement
-
Alzheimer’s drug slows progression in patients. It may soon be approved in U.S.Another experimental Alzheimer’s drug can modestly slow patients’ inevitable worsening — by about four to seven months, researchers reported Monday.HealthJul 17, 2023
-
No insulin price cut coming for Canada despite U.S. slashes, Eli Lilly saysEli Lilly and Co. announced Wednesday that it will cut prices for some of its most commonly prescribed insulin products in the United States.CanadaMar 3, 2023
-
-
Drugmaker Eli Lilly slashes prices, will offer $35 insulin in U.S. pharmaciesIn addition to slashing some drug prices by 70 per cent, Eli Lilly also promised to expand an existing program that caps some insulin products at $50.U.S. NewsMar 1, 2023
-
-
FDA authorizes new antibody drug that targets Omicron COVID-19 variantThe Food and Drug Administration said it cleared the Eli Lilly drug for adults and adolescent patients with mild-to-moderate cases of COVID-19.WorldFeb 11, 2022
-
U.S. limits use of Regeneron, Eli Lilly COVID-19 antibody treatments amid Omicron spreadLast month, the U.S. had paused the distribution of Regeneron and Lilly's treatments and said the halt would continue until new data emerges on their efficacy against Omicron.HealthJan 24, 2022
-
-
Advertisement
-
Standard drugs used to fight COVID-19 may not work against Omicron: U.S. doctorsThe shrinking toolbox of treatments is a painful reminder that COVID-19 still has the upper hand in the U.S., even with more than 200 million Americans fully vaccinated.HealthDec 19, 2021
-
-
Advertisement
-
U.S. drugmaker Lilly to submit ‘breakthrough’ Alzheimer’s drug to FDAThe drugmaker said Thursday that it plans to submit its potential treatment donanemab to the Food and Drug Administration later this year.HealthJun 24, 2021
Trending
-
‘No rush’ for snap election in Canada after Trump win, experts say60 Read
-
43 monkeys escape U.S. research facility; residents told to lock doors, windows40 Read
-
Couple finds 115 stuffed animals hidden in walls during B.C. renovation40 Read
-
Halifax school asked military to ditch the uniforms for Remembrance Day29 Read
-
Here’s how U.S. presidential term limits work as Trump prepares for return15 Read
-
Woman’s family wants it known her death by ex-RCMP officer was intimate partner violence14 Read
-
Top Videos
-
Changes to the Temporary Foreign Worker Program120 Viewed
-
What does a 2nd Trump presidency mean for Canada?85 Viewed
-
Canada’s restaurant industry on changes to the temporary foreign workers program77 Viewed
-
Vancouver Island couple makes amazing discovery behind wall74 Viewed
-
Immigration lawyer calls Ottawa’s move to limit temporary foreign workers ‘political’57 Viewed
-
Activists support fouled B.C. trans athlete45 Viewed
-